COVID-19 mRNA vaccination and myocarditis or pericarditis

Furthermore, this association has been established using multiple types of analysis, including comparisons of observed-to-expected rates,6,8,9 case-control studies,2 self-controlled cases series,3,4 and cohort studies.4,5,7 In The Lancet, Hui-Lee Wong and colleagues10 robustly replicate the previous...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) Vol. 399; no. 10342; pp. 2168 - 2169
Main Authors: Husby, Anders, Køber, Lars
Format: Journal Article
Language:English
Published: England Elsevier Ltd 11.06.2022
Elsevier Limited
Subjects:
Comment
Coronaviruses
COVID-19
COVID-19 - prevention & control
COVID-19 vaccines
Heart diseases
Humans
Immunization
mRNA
mRNA vaccines
Myocarditis
Pericarditis
Population studies
RNA, Messenger
Severe acute respiratory syndrome coronavirus 2
Surveillance
Vaccination
ISSN:0140-6736, 1474-547X, 1474-547X
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Furthermore, this association has been established using multiple types of analysis, including comparisons of observed-to-expected rates,6,8,9 case-control studies,2 self-controlled cases series,3,4 and cohort studies.4,5,7 In The Lancet, Hui-Lee Wong and colleagues10 robustly replicate the previous findings using large-scale US health plan claims data. [...]increased awareness about myocarditis and pericarditis in the population could have lowered barriers to health-care-seeking behaviour and hospital admission, possibly contributing to surveillance bias. [...]the use of claims databases as the source of study material provides little specification of the demographic composition of the study population, with no information on the race, ethnicity, or socioeconomic background of the individuals studied.
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Commentary-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
ObjectType-Commentary-3
content type line 23
ISSN:0140-6736
1474-547X
1474-547X
DOI:10.1016/S0140-6736(22)00842-X